Optimizing cyclosporine A dose post allogeneic hematopoietic stem cell transplantation in paediatric cancer patients

Background/Objectives Cyclosporine A (CSA) dosing has been complicated by considerable intra-patient and inter-patient variability in pharmacokinetics, which is affected by different factors. We aimed to assess the various factors that might affect the CSA dose and its plasma level. Patients and met...

Ausführliche Beschreibung